Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer ; volume:99 ; number:1 ; year:2021 ; pages:49-56
Oncology ; 99, Heft 1 (2021), 49-56
- Urheber
-
Jiang, Di Maria
Sim, Hao-Wen
Espin-Garcia, Osvaldo
Chan, Bryan A.
Natori, Akina
Lim, Charles H.
Moignard, Stephanie
Chen, Eric X.
Liu, Geoffrey
Darling, Gail
Swallow, Carol J.
Brar, Savtaj
Brierley, James
Ringash, Jolie
Wong, Rebecca
Kim, John
Rogalla, Patrik
Hafezi-Bakhtiari, Sara
Knox, Jennifer J.
Jang, Raymond W.
Elimova, Elena
- DOI
-
10.1159/000510446
- URN
-
urn:nbn:de:101:1-2021011323172966223435
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jiang, Di Maria
- Sim, Hao-Wen
- Espin-Garcia, Osvaldo
- Chan, Bryan A.
- Natori, Akina
- Lim, Charles H.
- Moignard, Stephanie
- Chen, Eric X.
- Liu, Geoffrey
- Darling, Gail
- Swallow, Carol J.
- Brar, Savtaj
- Brierley, James
- Ringash, Jolie
- Wong, Rebecca
- Kim, John
- Rogalla, Patrik
- Hafezi-Bakhtiari, Sara
- Knox, Jennifer J.
- Jang, Raymond W.
- Elimova, Elena
Ähnliche Objekte (12)
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Expressionsanalyse von Serum-Markern bei fortgeschrittenen Kopf-Hals-Tumoren und Carboplatin-5-Fluorouracil-Chemotherepie
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Expressionsanalyse von Serum-Markern bei fortgeschrittenen Kopf-Hals-Tumoren und Carboplatin-5-Fluorouracil-Chemotherepie
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Expressionsanalyse von Serum-Markern bei fortgeschrittenen Kopf-Hals-Tumoren und Carboplatin-5-Fluorouracil-Chemotherepie